Fuller & Thaler Holds 5.33% Of Prestige Consumer Healthcare In Passive Stake

The investment adviser reported 2,527,139.37 shares as of September 30 and certified that it does not seek to influence control.

Share
Fuller & Thaler Holds 5.33% Of Prestige Consumer Healthcare In Passive Stake

Fuller & Thaler Asset Management, an investment adviser, reported a 5.33% stake in Prestige Consumer Healthcare, which sells branded consumer health products, in a passive ownership disclosure filed Monday. The position was measured as of September 30, rather than the filing day.

The Holding And Voting Power

Fuller & Thaler reported 2,527,139.37 shares of Prestige's common stock. It held sole voting power over 2,522,247.37 shares and shared voting power over none.

The adviser certified that the shares were bought and held as part of its regular business, without a purpose or effect of changing or influencing Prestige's control.

Clear Eyes And Retail Customers

Prestige's brands include the Clear Eyes eye-care line. It sells mainly through drugstores, convenience stores, specialty retailers and e-commerce platforms, and most of its growth has come from buying brands and companies.

Walmart accounted for about 20% of gross revenues in fiscal 2026, while Amazon accounted for about 15%. They were its only customers above 10% of gross revenues that fiscal year.

Prestige operates three manufacturing facilities across the United States, Canada and Australia. Those facilities make products accounting for 21% of gross revenues; a third party handles U.S. distribution from Clayton, Indiana.

Its international business generated about 16% of total fiscal 2026 revenues and relies mainly on brokers and distributors. Prestige's market value was $2.2 billion in Monday trading as of 1:14 p.m. ET.

Sources

More on Prestige Consumer Healthcare

All Prestige Consumer Healthcare (PBH) coverage →